Previous close | 0.1227 |
Open | 0.1176 |
Bid | 0.1149 x 900 |
Ask | 0.1152 x 1300 |
Day's range | 0.1105 - 0.1295 |
52-week range | 0.0950 - 1.9800 |
Volume | |
Avg. volume | 12,136,261 |
Market cap | 14.133M |
Beta (5Y monthly) | 1.14 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CHICAGO, May 16, 2022--Exicure today reported financial results for the quarter ended March 31, 2022 and provided an update on its business strategy and corporate progress.
CHICAGO, May 10, 2022--Exicure, Inc.® (NASDAQ:XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity ("PIPE") financing. The purch
CHICAGO, May 09, 2022--Exicure, Inc. today announced a poster presentation at TIDES USA 2022, May 9-12, 2022.